Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.

Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J.

Circulation. 2009 Jun 2;119(21):2765-71. doi: 10.1161/CIRCULATIONAHA.108.808733.

3.

The relationship of vitamin D status to risk of cardiovascular disease and mortality.

Skaaby T.

Dan Med J. 2015 Feb;62(2). pii: B5008. Review.

PMID:
25634511
4.

How abnormal calcium, phosphate, and parathyroid hormone relate to cardiovascular disease.

Bro S.

Nephrol Nurs J. 2003 Jun;30(3):275-81; quiz 282-3. Review.

PMID:
12861895
5.

Mineral metabolism disturbances in patients with chronic kidney disease.

Kestenbaum B, Belozeroff V.

Eur J Clin Invest. 2007 Aug;37(8):607-22. Review.

PMID:
17635571
6.

Vitamin D and disease prevention with special reference to cardiovascular disease.

Zittermann A.

Prog Biophys Mol Biol. 2006 Sep;92(1):39-48. Review.

PMID:
16600341
7.

Calcium, calcium regulatory hormones, and calcimimetics: impact on cardiovascular mortality.

Schmitt CP, Odenwald T, Ritz E.

J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S78-80. Review.

8.

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease.

Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D.

Nephrol Dial Transplant. 2009 May;24(5):1506-23. doi: 10.1093/ndt/gfn613. Review.

PMID:
19001560
9.

Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.

Ryding AD, Kumar S, Worthington AM, Burgess D.

Anesthesiology. 2009 Aug;111(2):311-9. doi: 10.1097/ALN.0b013e3181aaeb11. Review.

PMID:
19602961
10.

Vitamin D and cardiovascular disease risk.

Michos ED, Melamed ML.

Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):7-12. Review.

PMID:
18090651
11.

Epidemiological aspects of cardiovascular disease in the elderly.

Fletcher AE, Bulpitt CJ.

J Hypertens Suppl. 1992 Apr;10(2):S51-8. Review.

PMID:
1593303
12.

Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials.

Björkman M, Sorva A, Tilvis R.

Arch Gerontol Geriatr. 2009 Mar-Apr;48(2):160-6. doi: 10.1016/j.archger.2007.12.005. Review.

PMID:
18243368
13.

Existing and potentially novel functional markers of vitamin D status: a systematic review.

Seamans KM, Cashman KD.

Am J Clin Nutr. 2009 Jun;89(6):1997S-2008S. doi: 10.3945/ajcn.2009.27230D. Review.

14.

Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology.

D'Amour P, Brossard JH.

Curr Opin Nephrol Hypertens. 2005 Jul;14(4):330-6. Review.

PMID:
15931000
15.

Association of serum albumin and mortality risk.

Goldwasser P, Feldman J.

J Clin Epidemiol. 1997 Jun;50(6):693-703. Review.

PMID:
9250267
16.

Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF.

J Am Coll Cardiol. 2008 Dec 9;52(24):1949-56. doi: 10.1016/j.jacc.2008.08.050. Review.

17.

Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.

Felsenfeld AJ, Rodríguez M, Aguilera-Tejero E.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1283-305. Review.

18.

Neonatal hypercalcemia.

Rodríguez Soriano J.

J Nephrol. 2003 Jul-Aug;16(4):606-8. Review.

PMID:
14696768
19.

Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study.

Shlipak MG, Fried LF, Stehman-Breen C, Siscovick D, Newman AB.

Am J Geriatr Cardiol. 2004 Mar-Apr;13(2):81-90. Review.

PMID:
15010654
20.

Diagnosis of hyperparathyroidism.

Davis PJ, Davis FB.

Otolaryngol Head Neck Surg. 1985 Feb;93(1):62-4. Review.

PMID:
2984631

Supplemental Content

Support Center